These Marijuana Stocks are About to Explode…

Your guide to marijuana stocks and exchanges


If one thing is true, the world is so incredibly fascinated by medical marijuana and its legalization process in the United States. Little by little, more and more states in America are becoming canna legal, and even more have already become 420 friendly.

Currently in the USA, 7 states plus the District of Columbia are recognized as legal. Those states include, Oregon, Washington, Alaska, Colorado, California, Maine, Nevada and Massachusetts. In addition, 19 states plus the District of Columbia recognize medical marijuana, and therefore it can be purchased if you are registered as a patient. With recent elections, laws are only predicted to become more allowing.

Not everyone lives in a state with this type of purchasing freedom… but an aspect many don’t consider when thinking about medical marijuana is the industry of investing in marijuana stocks. If you can’t purchase the real product… you might want to Make Money by Trading Pot Stocks.

Here are 4 Marijuana Stocks that you should keep your eye out for:

1. Stevia Corp. (STEV):

A leading management company of stevia sweetener production, a substance currently found in over 6,000 products. Stevia Corp. is currently not only interested in the production and sales of stevia, but now is also integrating into the hemp market and the products that can be produced with the utilization of hemp. Stevia Corps new LLC, called Real Hemp LLC, is focusing in on purchasing products made from hemp (cannabis) ranging from seeds to CBD extracts, a treatment currently used in some states and countries for treatment of various illnesses. Stevia Corp. is truly entering into a cutting edge industry and market, sitting right at the verge of a huge cannabis boom.

2. Oxis International (OXIS):

A BioTech company focusing on CBD research and recently entering the cannabis BioTech world. Oxis specializes in immunotherapy for the treatment of cancer, conducting research on the use of CBD’s for such treatments. Oxis is considered a forefront leader of the new up and coming cannabis market, even having specialists such as Dr. James J Mulé joining the Board of Scientific Advisory. This company combines masterful specialists with real CBD treatments, in part the reason why so many have already gained interest in this thriving BioTech corporation that is taking part in a huge marijuana revolution.

3. Insys Therapeutics, Inc. (INSY):

A cutting-edge pharmaceutical company focused on the treatment of Glioblastoma Multiforme (GBM), a malignant brain tumor that affects many globally. Insys is currently developing CBD oils that are synthetic, therefore guaranteeing a 99 percent purity, a technique that is brand new to the cannabis market. This type of development could be extremely beneficial to patients worldwide, for it will provide them with a potent alternative treatment that they can guarantee is pure and clean, without many of the nasty side effects of traditional medicines. Additionally, this company is one of the few that would be capable of producing large quantities of CBD pharmaceutical products. Therefore, Insys is an important investment in the current state of the medical cannabis world.

Related Article: How to Make Money from Pot Stocks

4. GW Pharmaceuticals (GWPH):

A biopharmaceutical company actively focused on the development and exposure of cannabinoid medicines to the standard market, so that it may be accessed for medical purposes in America and globally for various disease and illness treatments. Currently, GW Pharmaceuticals has released a prescription medicine known as Sativex®, a CBD medicine currently available in 11 countries, with 13 other countries soon to have this pharmaceutical available. The US, however, unfortunately has not approved this medication. GW Pharmaceuticals strives to change this barrier and get Sativex®, as well as a series of other CBD medications, commercialized and available worldwide.

With so many companies sitting on the edge of a 420 revolution, it may be right to invest in these up and coming corporate marijuana stocks who are truly changing the pharmaceutical and agricultural industries into a series of CBD based concepts that the world has never seen nor experienced before.